Suppr超能文献

DNA 甲基化的读者,MBD 家族作为潜在的治疗靶点。

Readers of DNA methylation, the MBD family as potential therapeutic targets.

机构信息

Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA 23298, United States; Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, United States; Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, United States.

Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.

出版信息

Pharmacol Ther. 2018 Apr;184:98-111. doi: 10.1016/j.pharmthera.2017.11.002. Epub 2017 Nov 8.

Abstract

DNA methylation represents a fundamental epigenetic modification that regulates chromatin architecture and gene transcription. Many diseases, including cancer, show aberrant methylation patterns that contribute to the disease phenotype. DNA methylation inhibitors have been used to block methylation dependent gene silencing to treat hematopoietic neoplasms and to restore expression of developmentally silenced genes. However, these inhibitors disrupt methylation globally and show significant off-target toxicities. As an alternative approach, we have been studying readers of DNA methylation, the 5-methylcytosine binding domain family of proteins, as potential therapeutic targets to restore expression of aberrantly and developmentally methylated and silenced genes. In this review, we discuss the role of DNA methylation in gene regulation and cancer development, the structure and function of the 5-methylcytosine binding domain family of proteins, and the possibility of targeting the complexes these proteins form to treat human disease.

摘要

DNA 甲基化是一种重要的表观遗传修饰,它调节染色质结构和基因转录。许多疾病,包括癌症,都表现出异常的甲基化模式,这些模式导致了疾病表型。DNA 甲基化抑制剂已被用于阻断依赖甲基化的基因沉默,以治疗造血肿瘤,并恢复发育性沉默基因的表达。然而,这些抑制剂会全局地破坏甲基化,并表现出显著的脱靶毒性。作为一种替代方法,我们一直在研究 DNA 甲基化的读取器,即 5-甲基胞嘧啶结合域家族蛋白,作为恢复异常和发育性甲基化和沉默基因表达的潜在治疗靶点。在这篇综述中,我们讨论了 DNA 甲基化在基因调控和癌症发展中的作用、5-甲基胞嘧啶结合域家族蛋白的结构和功能,以及靶向这些蛋白形成的复合物治疗人类疾病的可能性。

相似文献

2
Epigenetic Targets and their Inhibitors in Cancer Therapy.癌症治疗中的表观遗传学靶点及其抑制剂。
Curr Top Med Chem. 2018;18(28):2395-2419. doi: 10.2174/1568026619666181224095449.
5
Targeting DNA methylation with small molecules: what's next?用小分子靶向DNA甲基化:接下来会怎样?
J Med Chem. 2015 Mar 26;58(6):2569-83. doi: 10.1021/jm500843d. Epub 2014 Dec 4.
7
DNA methylation and cancer.DNA甲基化与癌症。
J Cell Physiol. 2000 May;183(2):145-54. doi: 10.1002/(SICI)1097-4652(200005)183:2<145::AID-JCP1>3.0.CO;2-V.
9
DNA methylation and gene silencing in cancer.癌症中的DNA甲基化与基因沉默。
Nat Clin Pract Oncol. 2005 Dec;2 Suppl 1:S4-11. doi: 10.1038/ncponc0354.

引用本文的文献

8
The epigenetic modification of DNA methylation in neurological diseases.神经疾病中的 DNA 甲基化的表观遗传修饰。
Front Immunol. 2024 Sep 23;15:1401962. doi: 10.3389/fimmu.2024.1401962. eCollection 2024.

本文引用的文献

6
Azacitidine in adult patients with acute myeloid leukemia.阿扎胞苷用于成年急性髓系白血病患者。
Crit Rev Oncol Hematol. 2017 Aug;116:159-177. doi: 10.1016/j.critrevonc.2017.05.010. Epub 2017 Jun 3.
9
DNA methylation markers for diagnosis and prognosis of common cancers.用于常见癌症诊断和预后的 DNA 甲基化标志物。
Proc Natl Acad Sci U S A. 2017 Jul 11;114(28):7414-7419. doi: 10.1073/pnas.1703577114. Epub 2017 Jun 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验